Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1563-258X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity ; day:8 ; month:2 ; year:2022 ; pages:1-9
Wiener medizinische Wochenschrift ; (8.2.2022), 1-9
- Creator
-
Hegen, Harald
Berek, Klaus
Deisenhammer, Florian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10354-022-00912-7
- URN
-
urn:nbn:de:101:1-2022051507042366358508
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hegen, Harald
- Berek, Klaus
- Deisenhammer, Florian
- SpringerLink (Online service)
Other Objects (12)
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
Cerebrospinal fluid analysis in multiple sclerosis
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome
Cerebrospinal fluid cells immune landscape in multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
Cerebrospinal fluid ubiquitin as a biomarker in neurological diseases
Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases
N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis
Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid
Cerebrospinal fluid research
Cerebrospinal fluid rhinorrhea
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
Cerebrospinal fluid analysis in multiple sclerosis
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome
Cerebrospinal fluid cells immune landscape in multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
Cerebrospinal fluid ubiquitin as a biomarker in neurological diseases
Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases
N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis
Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid
Cerebrospinal fluid research
Cerebrospinal fluid rhinorrhea
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
Cerebrospinal fluid analysis in multiple sclerosis
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome
Cerebrospinal fluid cells immune landscape in multiple sclerosis
Primary progressive multiple sclerosis (PPMS) – cerebrospinal fluid (CSF) profile
Cerebrospinal fluid ubiquitin as a biomarker in neurological diseases
Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases
N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis
Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid
Cerebrospinal fluid research